NEW YORK (GenomeWeb) – Thermo Fisher Scientific and Cynvenio Biosystems have signed a distribution agreement for Cynvenio's LiquidBiopsy platform, the companies said today.
Cynvenio's LiquidBiopsy platform is designed to extract and isolate circulating tumor cells from a blood draw and prepare them for imaging and genomic analysis. According to Cynvenio's website, the platform uses a patented microfluidic chip to recover tumor cells from whole blood and can process up to four samples in under three hours.